These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18680175)

  • 1. Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution.
    Vessely C; Estey T; Randolph TW; Henderson I; Cooper J; Nayar R; Braun LJ; Carpenter JF
    J Pharm Sci; 2009 Sep; 98(9):2970-93. PubMed ID: 18680175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry.
    Estey T; Vessely C; Randolph TW; Henderson I; Braun LJ; Nayar R; Carpenter JF
    J Pharm Sci; 2009 Sep; 98(9):2994-3012. PubMed ID: 18781606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.
    Vessely C; Estey T; Randolph TW; Henderson I; Nayar R; Carpenter JF
    J Pharm Sci; 2007 Sep; 96(9):2375-89. PubMed ID: 17518359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens.
    Jones LS; Peek LJ; Power J; Markham A; Yazzie B; Middaugh CR
    J Biol Chem; 2005 Apr; 280(14):13406-14. PubMed ID: 15684430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
    Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
    PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants.
    Peek LJ; Martin TT; Elk Nation C; Pegram SA; Middaugh CR
    J Pharm Sci; 2007 Mar; 96(3):547-57. PubMed ID: 17080408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting alum-protein interactions.
    Huang M; Wang W
    Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of surface charge in the optimization of antigen-adjuvant interactions.
    Callahan PM; Shorter AL; Hem SL
    Pharm Res; 1991 Jul; 8(7):851-8. PubMed ID: 1924135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
    Levesque PM; de Alwis U
    Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a tetravalent botulinum vaccine.
    Shi DY; Liu FJ; Li ZY; Mao YY; Lu JS; Wang R; Pang XB; Yu YZ; Yang ZX
    Hum Vaccin Immunother; 2022 Nov; 18(5):2048621. PubMed ID: 35435814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adjuvant in mediating antigen structure and stability.
    Braun LJ; Eldridge AM; Cummiskey J; Arthur KK; Wuttke DS
    J Pharm Sci; 2012 Apr; 101(4):1391-9. PubMed ID: 22213631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
    Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.
    Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF
    Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Botulinum Toxoids: A Practical Guide for Production.
    Moreira GMSG; Moreira C; da Cunha CEP; Mendonça M; Conceição FR
    Methods Mol Biol; 2016; 1404():621-632. PubMed ID: 27076326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
    Kukreja RV; Singh BR
    Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neurotoxin associated proteins in the low pH induced structural changes in the botulinum neurotoxin complex.
    Chellappan G; Kumar R; Cai S; Singh BR
    Protein J; 2014 Dec; 33(6):557-64. PubMed ID: 25408485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.